Nipradilol: A β‐Adrenoceptor Antagonist with Nitric Oxide–Releasing Action

This publication has 51 references indexed in Scilit:

• Nipradilol
  Cardiovascular Drug Reviews, 2007
• The β adrenoreceptor antagonist, nipradilol, preserves the endothelial nitric oxide response in atherosclerotic vessels of rabbit
  Life Sciences, 1997
• Nipradilol, a new β-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats
  Heart and Vessels, 1997
• Nipradilol inhibits rat mesangial cell mitogenesis through the activation of soluble guanylate cyclase
  European Journal of Pharmacology: Molecular Pharmacology, 1993
• Evaluation of a new antianginal agent, nipradilol, in effort angina using holter monitoring.
  Japanese Heart Journal, 1988
• Structural determination of dog and human urinary metabolites of nipradilol (K-351), a new antihypertensive agent.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
• Effects of beta-blockers upon the blood pressure, mortality and cerebral injury in the salt-loaded SHRSP
  Japanese Heart Journal, 1983
• Cardiovascular effect of (3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-3-nitrato-2H-1-benzopyran) (K 351).
  Japanese Heart Journal, 1982
• Rapid dextran infusion in essential hypertension.
  Hypertension, 1979
• Decreased venous distensibility in borderline hypertension.
  Hypertension, 1979